Skip to main content
Clinical Trials/ITMCTR2100005078
ITMCTR2100005078
Not yet recruiting
Phase 1

Study on the clinical curative effect and mechanism of ''Jiawei Huanshao Dan'' on senile frailty syndrome

CHINA-JAPAN FRIENDSHIP HOSPITA0 sitesTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
senile frailty syndrome
Sponsor
CHINA-JAPAN FRIENDSHIP HOSPITA
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
CHINA-JAPAN FRIENDSHIP HOSPITA

Eligibility Criteria

Inclusion Criteria

  • 1\. Meet the diagnostic criteria of frailty.
  • 2\. Meet the diagnostic criteria of cognitive impairment.
  • 3\. Aged \>\=65 years, gender is not limited.
  • 4\. Voluntary participation in research and signed informed consent.

Exclusion Criteria

  • 1\. Patients with severe cognitive impairment and limited autonomous activities who cannot complete the assessment.
  • 2\. Patients in the acute or terminal stage of the disease.
  • 3\. Patients with severe cardiovascular and cerebrovascular, digestive system, respiratory system diseases, blood diseases, and malignant tumors.
  • 4\. The treatment drugs being received affect the research such as hormones, immunosuppressants, etc.
  • 5\. Those who are allergic to the research drug or have sensitive skin.
  • 6\. Those who have participated in other clinical trials in the past 3 months.
  • 7\. Patients who are deemed unsuitable to participate in clinical trials by the investigator, including those with poor compliance determined by the investigator.

Outcomes

Primary Outcomes

Not specified

Similar Trials